STANDARD BIOTOOLS INC. — Director's Dealing 2023

Jan 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-12-20

Reporting Person: Davis Jeremy Steven (SVP Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-20	Restricted Stock Units	$	A	250000	Acquired		Common Stock (250000.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of LAB common stock.

F2: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023.